Jan Korbecki

43PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer cell biologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 15, 2026
Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models.

|Mar 28, 2026
The Significance of CXCL1 in Cancer: An Overview of Molecular Mechanisms.

Jan Korbecki, Mateusz Bosiacki, Edyta Dzięciołowska-Baran

|Feb 27, 2026
The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM).

Jan Korbecki, Mateusz Bosiacki, Rafał Stelmach

|Dec 30, 2025
Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models.

Piotr Stasiak, Justyna Sopel, Julia Maria Lipowicz

|Sep 13, 2025
The Importance of Chemokines Activating CXCR1, CXCR2 and CXCR3 in Tumorigenesis as Potential Therapeutic Targets in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.

Jan Korbecki, Katarzyna Barczak, Beata Bosiacka

|Jun 26, 2025
Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs.

Piotr Stasiak, Justyna Sopel, Artur Płóciennik

Pageof 8

Frequent Collaborators

26 joint publications

Dariusz Chlubek

26 joint publications

Irena Baranowska-Bosiacka

12 joint publications

Donata Simińska

8 joint publications

Patrycja Kupnicka